» Articles » PMID: 30315966

Dioscin: A Diverse Acting Natural Compound with Therapeutic Potential in Metabolic Diseases, Cancer, Inflammation and Infections

Overview
Journal Pharmacol Res
Publisher Elsevier
Specialty Pharmacology
Date 2018 Oct 14
PMID 30315966
Citations 52
Authors
Affiliations
Soon will be listed here.
Abstract

Currently, the numbers of patients with cancer, fibrosis, diabetes, chronic kidney disease, stroke and osteoporosis are increasing fast and fast. It's critical necessary to discovery lead compounds for new drug development. Dioscin, one active compound in some medicinal plants, has anti-inflammation, immunoregulation, hypolipidemic, anti-viral, anti-fungal and anti-allergic effects. In recent years, dioscin has reached more and more attention with its potent effects to treat liver, kidney, brain, stomach and intestine damages, and metabolic diseases including diabetes, osteoporosis, obesity, hyperuricemia as well as its anti-cancer activities through adjusting multiple targets and multiple signals. Therefore, dioscin is a promising multi-target candidate to treat various diseases. This review paper summarized the progress on pharmacological activities and mechanisms of dioscin, which may provide useful data for development and exploration of this natural product in the further.

Citing Articles

The role of tribbles homolog 2 in cell proliferation.

Zhang W, Li M, Zhang M, Yan G, Tang C Cell Commun Signal. 2025; 23(1):5.

PMID: 39762856 PMC: 11702054. DOI: 10.1186/s12964-024-01985-0.


Targeting the BMI1-Noxa axis by Dioscin induces apoptosis in oral squamous cell carcinoma cells.

Fang J, Wang R, Li X, Wang X, Gong L, Lou A J Cancer. 2025; 16(1):110-121.

PMID: 39744574 PMC: 11660131. DOI: 10.7150/jca.100631.


Impact and mechanism study of dioscin on biological characteristics of colorectal cancer cells.

Cai X, Huang Z, Tu F, Yu J World J Gastrointest Oncol. 2024; 16(11):4456-4467.

PMID: 39554744 PMC: 11551639. DOI: 10.4251/wjgo.v16.i11.4456.


Metabolic regulation of the immune system in health and diseases: mechanisms and interventions.

Hu T, Liu C, Lei M, Zeng Q, Li L, Tang H Signal Transduct Target Ther. 2024; 9(1):268.

PMID: 39379377 PMC: 11461632. DOI: 10.1038/s41392-024-01954-6.


Insights into diosgenin against inflammatory bowel disease as functional food based on network pharmacology and molecular docking.

Cai M, Mao Y, Gao W, Wang Z, Mao J, Sha R Heliyon. 2024; 10(18):e37937.

PMID: 39323838 PMC: 11422009. DOI: 10.1016/j.heliyon.2024.e37937.